Skip to content
YSPYSPYSP210210210

Drawing based on the label description. No photo yet.

“The 5 mg tablets are orange film-coated, round, unscored tablets debossed with "YSP 210" on one side of the tablets”

YSP 210 pill

Pill with imprint YSP 210 is orange, round, 11 mm and has been identified as Felodipine 5 mg. It is used for high blood pressure and variant angina pectoris. It is supplied by Proficient Rx LP.

Felodipine 5 mg

Imprint
YSP 210
Strength
5 mg
Used for
High blood pressure and variant angina pectoris
Color
Orange
Shape
Round
Size
11 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Proficient Rx LP
Drug class
Calcium channel blocker (blood pressure and heart medicine)
NDC
71205-921, 61442-432, 71205-921-30, 71205-921-60, 71205-921-90, 71205-921-00, 71205-921-72, 71205-921-55, 61442-432-01, 61442-432-05, 71335-2175, 71335-2175-1, 72162-1743, 72162-1743-5, 51407-088, 51407-088-01, 51407-088-05, 63629-2018, 63629-2018-1

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Felodipine pills and guides

What is Felodipine used for?

Felodipine is used for high blood pressure and variant angina pectoris.

Medicine type
Calcium channel blocker (blood pressure and heart medicine)
Official uses from the US prescribing label

Felodipine extended-release tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (eg, on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Felodipine extended-release tablets, USP may be administered with other antihypertensive agents.

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows YSP 210 and the other side has no imprint.
  • It is orange, round, 11 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Felodipine

Inactive: Lactose Monohydrate, Hydroxypropyl Cellulose (110000 Wamw), Silicon Dioxide, Hypromellose 2208 (100 Mpa.s), Magnesium Stearate, Butylated Hydroxyanisole, Anhydrous Dibasic Calcium Phosphate, Polyethylene Glycol 1000, Titanium Dioxide

Also distributed by

Carlsbad Technology, Inc., Bryant Ranch Prepack, Golden State Medical Supply, Inc.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Felodipine pills